Search Clinical Trials Parent Therapeutic Areas: Oncology | Dermatology/Plastic Surgery
Malignant Melanoma
State
Country
California
Laverne : Research Site
A Randomized, Double-Blind, Multi-Center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
Los Angeles : Research Site:
A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma
A Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma
San Diego : Research Site:
A Study to Optimize the Dose of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Metastatic Malignant Melanoma
San Francisco : Research Site:
Santa Monica : Research Site
Santa Monica : Local Institution
A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
Vallejo : Research Site:
Colorado
Denver : Research Site:
Florida
Miami : Research Site:
Orlando : Research Site:
Tampa : Research Site:
Illinois
Chicago : Local Institution
Indiana
Indianapolis : Research Site
Kentucky
Hazard : Local Institution
Maryland
Baltimore : Research Site
Massachusetts
Boston : Research Site:
Minnesota
Rochester : Research Site:
Missouri
Columbia : Research Site:
St. Louis : Research Site:
Nevada
Las Vegas : Local Institution
New Mexico
Albuquerque : Research Site:
New York
New York : Research Site:
Oregon
Portland : Local Institution
Pennsylvania
Philadelphia : Research Site:
Pittsburgh : Research Site:
Rhode Island
Providence : Research Site:
Tennessee
Memphis : Research Site:
Nashville : Research Site:
Texas
Dallas : Research Site:
Houston : Research Site:
Houston : S. R. Burzynski Clinic
Phase II Study Of Antineoplatons A10 And AS2-1 In Patients With Malignant Melenoma
Virginia
Charlottesville : University of Virginia
Evaluation of the Effects of Local GM-CSF-in-adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes ( HIC # 8380)
Phase II Trial for the Evaluation of the Efficacy of Vaccination with Synthetic Melanoma Peptides Administered with GM-CSF-in-adjuvant in Patients with Advanced Melanoma HIC #10049
Washington
Seattle : Research Site:
Australia
Melbourne : Research Site:
Newcastle : Research Site:
Sydney : Research Site:
Austria
Wien : Research Site:
Canada
Calgary, AB : Research Site:
Edmonton, AB : Research Site:
Montreal, QC : Research Site:
France
Bordeaux : Research Site:
Marseille : Research Site:
Nantes : Research Site:
Germany
Kiel : Research Site:
Mannheim : Research Site:
Tübingen : Research Site:
Italy
Firenze : Research Site:
A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma.
Genova : Research Site:
Milano : Research Site:
A Study of Avastin (Bevacizumab) in Combination With Dacarbazine in Patients With Unresectable/Metastatic Melanoma.
Siena : Local Institution
Netherlands
Rotterdam : Research Site:
Russian Federation
Rayazan : Local Institution
Voronezh : Local Institution
Spain
Madrid : Research Site:
Valencia : Research Site:
Switzerland
Zürich : Research Site:
United Kingdom
Glasgow : Research Site:
Northwood : Research Site:
